A Focus on AML: Applying the Latest Research to Individualize Therapy

In this on-demand Webcast and downloadable slideset, Harry P. Erba, MD; Keith W. Pratz, MD; B. Douglas Smith, MD; and Richard M. Stone, MD, provide expert perspective on optimal treatment of patients with acute myeloid leukemia.
Harry P. Erba, MD
Keith W. Pratz, MD
B. Douglas Smith, MD
Richard M. Stone, MD

Clinical Thoughts

Harry P. Erba, MD, discusses the challenge of, and possible solution for, developing an effective trial for elderly patients with AML who are unfit for chemotherapy.

Harry P. Erba, MD Released: September 28, 2016

MRD testing in AML can identify patients in CR at higher risk of relapse, but there are considerable barriers to using MRD to guide treatment.

Richard M. Stone, MD Released: October 20, 2016

Treating elderly patients with AML is particularly challenging. The upcoming ASH conference will include presentations from numerous studies of novel approaches that promise to improve outcomes for these patients.

B. Douglas Smith, MD Released: November 14, 2016

Downloadable Slidesets

In this downloadable slideset, Keith W. Pratz, MD, reviews the key data regarding novel predictive and prognostic factors for acute myeloid leukemia.

Released: December 7, 2016

In this downloadable slideset, Harry P. Erba, MD, PhD, reviews the key data regarding current management of patients with relapsed acute myeloid leukemia.

Released: December 8, 2016

In this downloadable slideset, B. Douglas Smith, MD, reviews the key data regarding optimal management of patients with newly diagnosed acute myeloid leukemia.

Released: December 8, 2016

In this downloadable slideset, Richard M. Stone, MD, reviews the key data regarding promising investigational agents in clinical trials for acute myeloid leukemia.

Released: December 9, 2016

Individualizing Treatment for AML

In this on-demand Webcast, Harry P. Erba, MD, provides expert perspective on optimal treatment of patients with acute myeloid leukemia.

Harry P. Erba, MD Released: January 6, 2017

In this on-demand Webcast, Keith W. Pratz, MD, provides expert perspective on optimal treatment of patients with acute myeloid leukemia.

Keith W. Pratz, MD Released: January 6, 2017

In this on-demand Webcast, B. Douglas Smith, MD, provides expert perspective on optimal treatment of patients with acute myeloid leukemia.

B. Douglas Smith, MD Released: January 6, 2017

In this on-demand Webcast, Richard M. Stone, MD, provides expert perspective on optimal treatment of patients with acute myeloid leukemia.

Richard M. Stone, MD Released: January 6, 2017

Satellite Symposium Evaluation

If you attended the AML Satellite Symposium on December 2nd in San Diego but were unable to complete the evaluation form, please download it here.

Released: December 5, 2016
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by educational grants from
AbbVie
Agios Pharmaceuticals
Celgene Corporation
Daiichi Sankyo
Jazz Pharmaceuticals

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?